MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
July 5, 2005
Alyce Lomax
Business As Usual at Walgreen Walgreen's same-store sales for June certainly don't disappoint. Investors might question whether the retail pharmacy can keep up the great work. mark for My Articles similar articles
The Motley Fool
September 21, 2006
Vitaliy Katsenelson
Don't Hit the Panic Button Just Yet Wall Street plays the overreacting game; Walgreen and CVS suffer. These stocks have big tailwinds behind them. mark for My Articles similar articles
The Motley Fool
September 26, 2006
Ryan Fuhrmann
Jaw-Dropping Pill-Popping at Walgreen How much longer can investors count on Walgreen's stellar numbers? mark for My Articles similar articles
The Motley Fool
January 7, 2010
Gerard Torres
Walgreen Lives to Fight Another Day Despite recent success, Walgreen continues to face stiff competition. mark for My Articles similar articles
The Motley Fool
September 21, 2006
Nathan Parmelee
Wal-Mart Goes Generic The supposed most terrible retailer of all is doing a very good thing with generic drug sales. The program will, of course, benefit Wal-Mart by creating additional traffic to its stores. This move could change the game for a number of retailers over the next few years. mark for My Articles similar articles
The Motley Fool
June 10, 2010
Claire Stephanic
CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers. mark for My Articles similar articles
The Motley Fool
March 22, 2010
Dave Mock
A Big Upgrade for CVS Caremark This bullish call comes from more than just one analyst. mark for My Articles similar articles
The Motley Fool
February 2, 2005
Alyce Lomax
CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny. mark for My Articles similar articles
The Motley Fool
June 28, 2005
Mike Cianciolo
Just What Investors Prescribed With another quarter of stellar growth at Walgreen, the stock approaches its highest price ever. mark for My Articles similar articles
The Motley Fool
July 29, 2011
Shubh Datta
A Drug Retailer for Your Portfolio With a strong balance sheet, Walgreen looks like a good buy. mark for My Articles similar articles
The Motley Fool
October 2, 2007
Lawrence A. Rothman
Can the Right Prescription Heal Walgreen? Walgreen is suffering from heightened competition, expenses rising more than 11%, and the company itself predicting its challenges will probably continue into the near future. mark for My Articles similar articles
The Motley Fool
January 3, 2006
Stephen D. Simpson
Walgreen Reaps Rewards of Rx The nation's top pharmacy keeps on rolling, but investors might want to keep an eye on the new ventures. mark for My Articles similar articles
The Motley Fool
October 8, 2011
Shubh Datta
Impasse Hurts Walgreen's Quarter Walgreen posted a staggering 69% earnings jump but still saw its shares slide. mark for My Articles similar articles
The Motley Fool
February 3, 2006
Nathan Parmelee
CVS Looks Healthy The drugstore chain handles acquisitions without faltering -- this stock may be worth considering. mark for My Articles similar articles
The Motley Fool
November 14, 2006
Nathan Parmelee
Time to Love Wal-Mart Again Some pretty handsome returns can be earned by investors who pick up the retailer's shares on the days when there is bad news and hold patiently for a few years. mark for My Articles similar articles
The Motley Fool
December 26, 2006
Matthew Crews
Walgreen Represents This drugstore business has proven itself; does its stock match up? mark for My Articles similar articles
The Motley Fool
October 5, 2011
Shubh Datta
At Walgreen, It's Payback Time Walgreen buys back shares and raises its dividend. mark for My Articles similar articles
The Motley Fool
January 4, 2008
Timothy M. Otte
Drugstore Sales Droop in December The three major drugstore chains, Walgreen, CVS, and Rite Aid, all report soft sales for December. mark for My Articles similar articles
The Motley Fool
June 14, 2010
Rich Smith
Is CVS' $2 Billion Buyback Good Medicine? Don't assume just because CVS is buying its stock, that this is a good idea. mark for My Articles similar articles
The Motley Fool
April 9, 2007
Mike Cianciolo
CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note. mark for My Articles similar articles
The Motley Fool
March 22, 2004
Alyce Lomax
Walgreen's Green Quarter Investors take an earnings miss to heart. But the future looks good. mark for My Articles similar articles
The Motley Fool
June 26, 2007
Ryan Fuhrmann
Walgreen Sells Convenience Walgreen continues to grow market share, with little sign of slowing down. mark for My Articles similar articles
The Motley Fool
January 8, 2007
Matthew Crews
CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 29, 2010
Andrew Bond
Walgreen Surprises the Experts Walgreen posts a great quarter as competition falters. mark for My Articles similar articles
The Motley Fool
September 28, 2007
Timothy M. Otte
Foolish Forecast: Walgreen Still Minting the Green? In advance of fourth-quarter earnings, analysts expect the company to continue its record of four straight years of sales growth. mark for My Articles similar articles
The Motley Fool
March 1, 2010
Selena Maranjian
Investing for All the Wrong Reasons Unless it backs up its praise with sound logic, even the most complimentary description of your most beloved stock could steer you wrong. mark for My Articles similar articles
The Motley Fool
September 22, 2006
Ryan Fuhrmann
More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 3, 2005
Nathan Slaughter
Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground. mark for My Articles similar articles
The Motley Fool
June 21, 2004
Seth Jayson
Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore. mark for My Articles similar articles
The Motley Fool
November 3, 2011
A Brief History of Walgreen's Returns Walgreen's P/E ratio declined by more than 70% over the past 10 years. That's simply incredible. Every bit of Walgreen's earnings growth has been discounted by the market through lower valuations. mark for My Articles similar articles
The Motley Fool
May 7, 2007
Ryan Fuhrmann
The Dust Settles at OfficeMax Does recent share price weakness warrant investment consideration in OfficeMax? mark for My Articles similar articles
The Motley Fool
August 31, 2011
Shubh Datta
CVS Caremark Flattened by Higher Costs CVS Caremark profits remained relatively flat this quarter despite a substantial increase in revenue. mark for My Articles similar articles
The Motley Fool
May 5, 2004
Mike Cianciolo
CVS Prescribes Growth The soon-to-be leader of the drugstore market had a spectacular first quarter as a result of improved sales and margins, and CVS doesn't appear to be showing any signs of slowing down either, as the company continues to expand its business in both traditional and creative ways. mark for My Articles similar articles
The Motley Fool
September 27, 2004
Phil Wohl
Walgreen: Prescription for Success The leading drugstore retailer is leveraging prescription sales to produce record results. Fourth-quarter earnings grew to $0.32 per share, which was an 18% improvement over last year's $0.27. mark for My Articles similar articles
The Motley Fool
January 5, 2004
Jeff Hwang
Prescriptions Boost Walgreen Earnings and sales bumped by early flu season and improved non-pharmacy sales. mark for My Articles similar articles
The Motley Fool
March 24, 2011
Rick Aristotle Munarriz
It's a Dot-Com Drug Deal Gone Bad The drugstore giant acquires the drugstore.com pipsqueak. mark for My Articles similar articles
The Motley Fool
October 31, 2008
Timothy M. Otte
CVS Caremark Takes Care of Its Investors The drugstore giant continues to scoop up market share. mark for My Articles similar articles
The Motley Fool
May 4, 2011
Jason Knapp
Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will. mark for My Articles similar articles
The Motley Fool
September 23, 2005
Stephen D. Simpson
Waiting for Walgreen Earnings that disappoint Wall Street could be long-term investors' golden opportunity. Let's look toward Walgreen's earnings release next week and see if an opportunity will present itself. mark for My Articles similar articles
The Motley Fool
June 2, 2004
Alyce Lomax
Walgreen's Mellow May Will the drugstore chain get a taste of its own medicine? mark for My Articles similar articles
The Motley Fool
March 9, 2004
Alyce Lomax
February Frenzy at CVS, Rite Aid The flu season's early end hasn't stopped drugstore retailers. mark for My Articles similar articles
The Motley Fool
August 8, 2005
Mike Cianciolo
A Cautiously Optimistic CVS The retail pharmacy nudges guidance up after an impressive quarter. All things considered, the outlook seems bright for investors in this company. mark for My Articles similar articles
The Motley Fool
April 25, 2006
Alyce Lomax
Coach Gets Bagged Investors fret over Coach's guidance, but are they overreacting? Its nearly 8% drop in share price today might just be a point when opportunistic investors start thinking that high-end Coach is becoming a bit more of a bargain. mark for My Articles similar articles
The Motley Fool
July 26, 2010
Seth Jayson
Show Me the Money, Walgreen All cash flow is not created equal. mark for My Articles similar articles
The Motley Fool
November 2, 2006
Ryan Fuhrmann
CVS Blazes a New Healthcare Trail Strong third-quarter earnings aside, the merger announcement with pharmacy benefit manager Caremark was the real shocker here. Investors, take note. mark for My Articles similar articles
The Motley Fool
June 6, 2006
Ryan Fuhrmann
Harry's Happy With Walgreen Walgreen acquires the Happy Harry's pharmacy chain. Investors, take note. mark for My Articles similar articles
The Motley Fool
September 14, 2006
Ryan Fuhrmann
Playing Defense With the Drugstore Industry Retail pharmacy August sales trends help investors discern the leader in this appealing sector. mark for My Articles similar articles
The Motley Fool
July 6, 2007
Lawrence Rothman
Walgreen Does It Again The company continues to impress, posting positive same-store sales results month after month. At a P/E of 21, this stock isn't especially rich, given the solid performance that the company delivers. mark for My Articles similar articles
The Motley Fool
November 11, 2011
Dan Caplinger
Has Walgreen Become the Perfect Stock? Given that drug retail is a low-margin business, it's improbable that Walgreen will ever reach true perfection. But with some help, improving growth numbers is a goal that could be within reach. mark for My Articles similar articles
The Motley Fool
June 10, 2004
Alyce Lomax
Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition. mark for My Articles similar articles